THRM (Gentherm Inc) Stock Analysis - News

Gentherm Inc (THRM) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, THRM trades at $30.59 with a market cap of $930.45M and a P/E ratio of 41.37. THRM moved +0.00% today. Year to date, THRM is -17.26%; over the trailing twelve months it is +14.12%. Its 52-week range spans $22.75 to $49.32. Analyst consensus is buy with an average price target of $37.20. Rallies surfaces THRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in THRM news today?

Gentherm Showcases WellSense Heat-and-Massage Furniture at NeoCon June 7–10: At NeoCon June 7–10, Gentherm will unveil WellSense thermal-and-pneumatic comfort systems for home and office furniture, integrating configurable heat, massage and ventilation in recliners, chairs and desks. Backed by over 7,000 testing hours, 19 completed and 10 ongoing clinical studies, this push leverages its $1.5 billion 2025 sales and $2.2 billion in auto awards.

THRM Key Metrics

Key financial metrics for THRM
MetricValue
Price$30.59
Market Cap$930.45M
P/E Ratio41.37
EPS$0.75
Dividend Yield0.00%
52-Week High$49.32
52-Week Low$22.75
Volume4.17K
Avg Volume0
Revenue (TTM)$1.54B
Net Income$22.63M
Gross Margin24.24%

Latest THRM News

Recent THRM Insider Trades

  • Runyon Barbara J sold 3.35K (~$116.58K) on Aug 21, 2025.
  • Washington Kenneth E bought 1.70K (~$47.70K) on May 13, 2025.
  • Hundzinski Ronald T bought 5.00K (~$133.35K) on May 8, 2025.

THRM Analyst Consensus

6 analysts cover THRM: 0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $37.20.

Common questions about THRM

What changed in THRM news today?
Gentherm Showcases WellSense Heat-and-Massage Furniture at NeoCon June 7–10: At NeoCon June 7–10, Gentherm will unveil WellSense thermal-and-pneumatic comfort systems for home and office furniture, integrating configurable heat, massage and ventilation in recliners, chairs and desks. Backed by over 7,000 testing hours, 19 completed and 10 ongoing clinical studies, this push leverages its $1.5 billion 2025 sales and $2.2 billion in auto awards.
Does Rallies summarize THRM news?
Yes. Rallies summarizes THRM news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is THRM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for THRM. It does not provide personalized investment advice.
THRM

THRM